Court of Chancery Invalidates Election of Directors Where Board Improperly Set the Record Date
This case illustrates that the court generally will not use Section 205 to validate a deliberate, intentional violation of a ...
Delaware State Bar Association: Phil Shaw's claims about judiciary are unfounded
We categorically reject Phil Shawe's accusation that the Judiciary is “biased and ripe for abuse and corruption.” ...
Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement
Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining ...
Loews Corporation Announces Favorable Resolution of Boardwalk Pipelines Acquisition Litigation
Loews Corporation (NYSE: L) announced today that the Delaware Court of Chancery found no liability in connection with Loews's 2018 acquisition of the minority limited partner interests in its ...
The News Journal5d
Delaware State Bar Association: Phil Shaw's claims about judiciary are unfounded
Shawe says, “Since 2015, my $1.2 billion company that I founded in my grad school dorm room in 1992 has been trapped in a protracted legal battle with the [Delaware] Chancery Court.” ...
Alimera Files Lawsuit Against ANI To Enforce Merger Deal, Stock Down Nearly 19%
Alimera Sciences, Inc. (ALIM), a biopharmaceutical company, announced on Tuesday that it has filed a lawsuit in the Delaware Court of ...
Cencora Defends Director’s Investigation of Alleged Syringe Scam
Pension funds sought Wednesday to undermine a single-member AmerisourceBergen Corp. board committee, whose findings pushed a ...
Masimo Pulls Opposition in Delaware to Politan’s Board Nominees
Masimo Corp. won’t continue to oppose Politan Capital Management LP’s nomination of two candidates to its board of directors ...
Alimera Sciences falls after it sues ANI Pharmaceuticals to close deal (update)
Alimera Sciences files lawsuit against ANI Pharmaceuticals over failed merger, causing stock to plummet 25% in premarket ...
Alimera Sciences Shares Slide on Merger Lawsuit
On June 24, ANI said it was buying Alimera Sciences for $5.50 per share in cash, in a deal that valued Alimera at $381 million. The offer represented a 75% premium to its closing share price of $3.15 ...